FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117201375> ?p ?o ?g. }

• W2117201375 abstract "Artemisinin derivatives may have advantages over quinoline drugs for treating severe malaria since they are fast acting and effective against quinine resistant malaria parasites.The objective of this review was to assess the effects of artemisinin drugs for severe and complicated falciparum malaria in adults and children.We searched the Cochrane Infectious Diseases Group trials register, Cochrane Controlled Trials Register, Medline, Embase, Science Citation Index, Lilacs, African Index Medicus, conference abstracts and reference lists of articles. We contacted organisations, researchers in the field and drug companies.Randomised and pseudo-randomised trials comparing artemisinin drugs (rectal, intramuscular or intravenous) with standard treatment, or comparisons between artemisinin derivatives in adults or children with severe or complicated falciparum malaria.Eligibility, trial quality assessment and data extraction were done independently by two reviewers. Study authors were contacted for additional information.Twenty three trials are included, allocation concealment was adequate in nine. Sixteen trials compared artemisinin drugs with quinine in 2653 patients. Artemisinin drugs were associated with better survival (mortality odds ratio 0.61, 95% confidence interval 0.46 to 0.82, random effects model). In trials where concealment of allocation was adequate (2261 patients), this was barely statistically significant (odds ratio 0.72, 95% CI 0.54 to 0.96, random effects model). In 1939 patients with cerebral malaria, mortality was also lower with artemisinin drugs overall (odds ratio 0.63, 95% CI 0.44 to 0.88, random effects model). The difference was not significant however when only trials reporting adequate concealment of allocation were analysed (odds ratio 0.78, 95% CI 0.55 to 1.10, random effects model) based on 1607 patients. No difference in neurological sequelae was shown. Compared with quinine, artemisinin drugs showed faster parasite clearance from the blood and similar adverse effects.The evidence suggests that artemisinin drugs are no worse than quinine in preventing death in severe or complicated malaria. No artemisinin derivative appears to be better than the others." @default.
• W2117201375 created "2016-06-24" @default.
• W2117201375 creator A5011727462 @default.
• W2117201375 creator A5054185332 @default.
• W2117201375 date "1998-07-27" @default.
• W2117201375 modified "2023-10-17" @default.
• W2117201375 title "Artemisinin derivatives for treating severe malaria" @default.
• W2117201375 cites W1513988717 @default.
• W2117201375 cites W1517520832 @default.
• W2117201375 cites W1591259115 @default.
• W2117201375 cites W1975325875 @default.
• W2117201375 cites W1976738596 @default.
• W2117201375 cites W1986708648 @default.
• W2117201375 cites W1991072114 @default.
• W2117201375 cites W2017504348 @default.
• W2117201375 cites W2030428877 @default.
• W2117201375 cites W2040666770 @default.
• W2117201375 cites W2042935148 @default.
• W2117201375 cites W2046385047 @default.
• W2117201375 cites W2050330644 @default.
• W2117201375 cites W2056007935 @default.
• W2117201375 cites W2057595608 @default.
• W2117201375 cites W2059397542 @default.
• W2117201375 cites W2061409637 @default.
• W2117201375 cites W2063007022 @default.
• W2117201375 cites W2069395262 @default.
• W2117201375 cites W2074577972 @default.
• W2117201375 cites W2083943739 @default.
• W2117201375 cites W2094478720 @default.
• W2117201375 cites W2104312285 @default.
• W2117201375 cites W2145322572 @default.
• W2117201375 cites W2157823046 @default.
• W2117201375 cites W2164022492 @default.
• W2117201375 cites W2166853845 @default.
• W2117201375 cites W2181657564 @default.
• W2117201375 cites W2181911434 @default.
• W2117201375 cites W2233190715 @default.
• W2117201375 cites W2275531380 @default.
• W2117201375 cites W2295956374 @default.
• W2117201375 cites W2313139941 @default.
• W2117201375 cites W2320022633 @default.
• W2117201375 cites W2399708326 @default.
• W2117201375 cites W2401889611 @default.
• W2117201375 cites W2408518028 @default.
• W2117201375 cites W2413973941 @default.
• W2117201375 cites W2416287458 @default.
• W2117201375 cites W283813553 @default.
• W2117201375 cites W4244827160 @default.
• W2117201375 cites W4251762624 @default.
• W2117201375 cites W4254041232 @default.
• W2117201375 cites W4299572512 @default.
• W2117201375 cites W4302357340 @default.
• W2117201375 cites W43777240 @default.
• W2117201375 doi "https://doi.org/10.1002/14651858.cd000527" @default.
• W2117201375 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6532607" @default.
• W2117201375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10796551" @default.
• W2117201375 hasPublicationYear "1998" @default.
• W2117201375 type Work @default.
• W2117201375 sameAs 2117201375 @default.
• W2117201375 citedByCount "61" @default.
• W2117201375 countsByYear W21172013752012 @default.
• W2117201375 countsByYear W21172013752013 @default.
• W2117201375 countsByYear W21172013752014 @default.
• W2117201375 countsByYear W21172013752015 @default.
• W2117201375 countsByYear W21172013752016 @default.
• W2117201375 countsByYear W21172013752017 @default.
• W2117201375 countsByYear W21172013752018 @default.
• W2117201375 countsByYear W21172013752019 @default.
• W2117201375 countsByYear W21172013752020 @default.
• W2117201375 countsByYear W21172013752021 @default.
• W2117201375 countsByYear W21172013752022 @default.
• W2117201375 countsByYear W21172013752023 @default.
• W2117201375 crossrefType "journal-article" @default.
• W2117201375 hasAuthorship W2117201375A5011727462 @default.
• W2117201375 hasAuthorship W2117201375A5054185332 @default.
• W2117201375 hasBestOaLocation W21172013752 @default.
• W2117201375 hasConcept C126322002 @default.
• W2117201375 hasConcept C156957248 @default.
• W2117201375 hasConcept C168563851 @default.
• W2117201375 hasConcept C203014093 @default.
• W2117201375 hasConcept C2776120307 @default.
• W2117201375 hasConcept C2777617192 @default.
• W2117201375 hasConcept C2778048844 @default.
• W2117201375 hasConcept C2778059366 @default.
• W2117201375 hasConcept C2778371730 @default.
• W2117201375 hasConcept C44249647 @default.
• W2117201375 hasConcept C535046627 @default.
• W2117201375 hasConcept C71924100 @default.
• W2117201375 hasConcept C82789193 @default.
• W2117201375 hasConceptScore W2117201375C126322002 @default.
• W2117201375 hasConceptScore W2117201375C156957248 @default.
• W2117201375 hasConceptScore W2117201375C168563851 @default.
• W2117201375 hasConceptScore W2117201375C203014093 @default.
• W2117201375 hasConceptScore W2117201375C2776120307 @default.
• W2117201375 hasConceptScore W2117201375C2777617192 @default.
• W2117201375 hasConceptScore W2117201375C2778048844 @default.
• W2117201375 hasConceptScore W2117201375C2778059366 @default.
• W2117201375 hasConceptScore W2117201375C2778371730 @default.
• W2117201375 hasConceptScore W2117201375C44249647 @default.
• W2117201375 hasConceptScore W2117201375C535046627 @default.

• next